| pubmed-article:18056190 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18056190 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18056190 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:18056190 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
| pubmed-article:18056190 | lifeskim:mentions | umls-concept:C0026986 | lld:lifeskim |
| pubmed-article:18056190 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:18056190 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:18056190 | lifeskim:mentions | umls-concept:C0205160 | lld:lifeskim |
| pubmed-article:18056190 | lifeskim:mentions | umls-concept:C2613365 | lld:lifeskim |
| pubmed-article:18056190 | pubmed:issue | 23 | lld:pubmed |
| pubmed-article:18056190 | pubmed:dateCreated | 2007-12-6 | lld:pubmed |
| pubmed-article:18056190 | pubmed:abstractText | Promoter hypermethylation of, for example, tumor-suppressor genes, is considered to be an important step in cancerogenesis and a negative risk factor for survival in patients with myelodysplastic syndromes (MDS); however, its role for response to therapy has not been determined. This study was designed to assess the effect of methylation status on the outcome of conventional induction chemotherapy. | lld:pubmed |
| pubmed-article:18056190 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18056190 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18056190 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18056190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18056190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18056190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18056190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18056190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18056190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18056190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18056190 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18056190 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18056190 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:JacobsenSten... | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:WallvikJonasJ | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:OlssonAnnaA | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:HoklandPeterP | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:Hellström-Lin... | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:KjeldsenLarsL | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:NilssonLarsL | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:BernellPerP | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:LinderOlleO | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:AstermarkJanJ | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:TangenJon... | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:ObergGunnarG | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:PorwitAnnaA | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:AggerholmAnni... | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:EngströmLena-... | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:KhanRasheedR | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:GrövdalMichae... | lld:pubmed |
| pubmed-article:18056190 | pubmed:author | pubmed-author:AntunovicPeta... | lld:pubmed |
| pubmed-article:18056190 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18056190 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:18056190 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:18056190 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18056190 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18056190 | pubmed:pagination | 7107-12 | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:meshHeading | pubmed-meshheading:18056190... | lld:pubmed |
| pubmed-article:18056190 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:18056190 | pubmed:articleTitle | Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome. | lld:pubmed |
| pubmed-article:18056190 | pubmed:affiliation | Division of Haematology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Denmark. | lld:pubmed |
| pubmed-article:18056190 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18056190 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:18056190 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18056190 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18056190 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18056190 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18056190 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18056190 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18056190 | lld:pubmed |
